Prognostic impact of ventilatory efficiency in heart disease patients with preserved exercise tolerance

Circulation Journal

Volumn 70, Issue 10, 2006, Pages 1332-1336

  Tsurugaya, Hideki ^a,b   Adachi, Hitoshi ^b   Kurabayashi, Masahiko ^a   Ohshima, Shigeru ^b   Taniguchi, Koichi ^b  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA PREFECTURAL CARDIOVASCULAR CENTER   (Japan)

Author keywords

Exercise tolerance; Heart disease; Prognosis; Ventilatory efficiency

Indexed keywords

CARBON DIOXIDE; OXYGEN;

ADULT; AGED; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CARDIOPULMONARY FUNCTION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; HEART DEATH; HEART DISEASE; HOSPITAL READMISSION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LUNG MINUTE VOLUME; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PROGNOSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TRICUSPID VALVE DISEASE;

AGED; CARDIOVASCULAR DISEASES; DISEASE-FREE SURVIVAL; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART DISEASES; HEART FUNCTION TESTS; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY GAS EXCHANGE;

EID: 33749039206     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.1332     Document Type: Article

References (28)

1. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991; 83: 778-786.
2. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 819-823.
3. Maeda K, Tsutamoto T, Wada A, Mabuchi N, Hayashi M, Tsutsui T, et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 2000; 36: 1587-1593.
4. Myers J, Walsh D, Buchanan N, Froelicher VF. Can maximal cardiopulmonary capacity be recognized by a plateau in oxygen uptake? Chest 1989; 96: 1312-1316.
5. Clark AL, Poole-Wilson PA, Coats AJ. Effects of motivation of the patient on indices of exercise capacity in chronic heart failure. Br Heart J 1994; 71: 162-165.
6. Fink LI, Wilson JR, Ferraro N. Exercise ventilation and pulmonary artery wedge pressure in chronic stable congestive heart failure. Am J Cardiol 1986; 57: 249-253.
7. Weber KT, Kinasewitz GT, Janicki JS, Fishman AP. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation 1982; 65: 1213-1223.
8. Clark AL, Volterrani M, Swan JW, Coats AJ. The increased ventilatory response to exercise in chronic heart failure: Relation to pulmonary pathology. Heart 1997; 77: 138-146.
9. Uren NG, Davies SW, Agnew JE, Irwin AG, Jordan SL, Hilson AJ, et al. Reduction of mismatch of global ventilation and perfusion on exercise is related to exercise capacity in chronic heart failure. Br Heart J 1993; 70: 241-246.
10. Sullivan MJ, Higginbotham MB, Cobb FR. Increased exercise ventilation in patients with chronic heart failure: Intact ventilatory control despite hemodynamic and pulmonary abnormalities. Circulation 1988; 77: 552-559.
11. A/Q in the dog. Appl Physiol 1982; 52: 245-253.
12. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-1906.
13. Chua TP, Clark AL, Amadi AA, Coats AJ. Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1996; 27: 650-657.
14. Narkiewicz K, Pesek CA, van de Borne PJ, Kato M, Somers VK. Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation 1999; 100: 262-267.
15. Ponikowski P, Francis DP, Piepoli MF, Davies LC, Chua TP, Davos CH, et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: Marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation 2001; 103: 967-972.
16. Milani RV, Mehra MR, Reddy TK, Lavie CJ, Ventura HO. Ventilation/carbon dioxide production ratio in early exercise predicts poor functional capacity in congestive heart failure. Heart 1996; 76: 393-396.
17. Megro K, Adachi H, Oshima S, Taniguchi K, Nagai R. Exercise tolerance, exercises hyperpnea and central chemosensitivity to carbon dioxide in sleep apnea syndrome in heart failure. Circ J 2005; 69: 695-699.
18. Eto Y, Koike A, Matsumoto A, Momomura S, Tajima A, Aizawa T, et al. Early aerobic training increases end-tidal CO2 pressure during exercise in patients after acute myocardial infarction. Circ J 2004; 68: 778-788.
19. Kleber FX, Vietzke G, Wernecke KD, Bauer U, Opitz C, Wensel R, et al. Impairment of ventilatory efficiency in heart failure: Prognostic impact. Circulation 2000; 101: 2803-2809.
20. Chua TP, Ponikowski P, Harrington D, Anker SD, Webb-Peploe K, Clark AL, et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997; 29: 1585-1590.
21. Gitt AK, Wasserman K, Kilkowski C, Kleemann T, Kilkowski A, Bangert M, et al. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation 2002; 106: 3079-3084.
22. Weber KT, Janicki JS. Gas transport and the cardiopulmonary unit. In: Cardiopulmonary Exercise Testing: Physiological Principles and Clinical Application. Philadelphia: WB Saunders; 1986; 15.
23. Stevenson LW. Selection and management of candidates for heart transplantation. Curr Opin Cardiol 1996; 11: 166-173.
24. 2. Eur Heart J 2000; 21: 154-161.
25. The EPOCH study Group. Effects of Pimopenndan on adverse cardiac events and physical activities in patients with mild moderate chronic heart failure: The effects of Pimobendan on chronic heart failure study (EPOCH study). Circ J 2002; 66: 149-157.
26. Persson MG, Gustafsson LE, Wiklund NP, Moncada S, Hedqvist P. Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo. Acta Physiol Scand 1990; 140: 449-457.
27. Koizumi T, Gupta R, Banerjee M, Newman JH. Changes in pulmonary vascular tone during exercise. Effects of nitric oxide (NO) synthase inhibition, L-arginine infusion, and NO inhalation. J Clin Invest 1994; 94: 2275-2282.
28. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993; 328: 1732-1739.